A diverse array of successful, first-generation SARS-CoV-2 vaccines have played a huge
role in efforts to bring the COVID-19 pandemic under control, even though inequitable …

The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …

Objective To quantify the risk of deep vein thrombosis, pulmonary embolism, and bleeding
after covid-19. Design Self-controlled case series and matched cohort study. Setting …

Emerging reports of rare neurological complications associated with COVID-19 infection and
vaccinations are leading to regulatory, clinical and public health concerns. We undertook a …

Background: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
induces a prothrombotic state, but long-term effects of COVID-19 on incidence of vascular …

The coronavirus disease 2019 (COVID-19) outbreak remains a major public health
challenge worldwide. The present study investigated the effect of COVID-19 on blood …

The risk-benefit profile of COVID-19 vaccination in children remains uncertain. A self-
controlled case-series study was conducted using linked data of 5.1 million children in …

Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …

Several studies have reported associations between COVID-19 vaccination and risk of
cardiac diseases, especially in young people; the impact on mortality, however, remains …

The first dose of COVID-19 vaccines led to an overall reduction in cardiovascular events,
and in rare cases, cardiovascular complications. There is less information about the effect of …